Recent Quotes
My Watchlist
Indicators
OGJ 150 Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:RMTG)

0.0600 UNCHANGED
Streaming Delayed Price Updated: 10:07 AM EST, Nov 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RMTG

News headline image
RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
Via ACCESS Newswire
News headline image
RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership
Via ACCESS Newswire
News headline image
RMTG Expands into Brazil with Strategic Representation Agreement
Via ACCESS Newswire
News headline image
RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries
Via ACCESS Newswire
News headline image
RMTG Partners with BKFC as Official Regenerative Medicine Provider
Via ACCESS Newswire
News headline image
RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit
Via ACCESS Newswire
News headline image
RMTG Achieves Operational Profitability Expands Sales by 52% for Q3 Year Over Year and Reaches Gross Profit Margin of 75% for Q3
Via ACCESSWIRE
News headline image
Regenerative Medical Technology Group Announces the Opening of New Clinic in Dubai on November 23
Via ACCESSWIRE
News headline image
RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership
Via ACCESS Newswire
News headline image
RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025
Via ACCESS Newswire
News headline image
RMTG Expands to Puerto Rico with New Affiliate Partnership
Via ACCESS Newswire
News headline image
Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000
Via ACCESS Newswire
News headline image
Regenerative Medical Technologies Group Increased 2024 Sales by 70% Year Over Year with Increased Q4 Sales by 146% Year Over Year and Achieved Positive Operating Income for 2024
Via ACCESS Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>